SummaryThe absence of pigment epithelium-derived factor (PEDF) in hepatocellular carcinoma (HCC) enhances Wnt/β-catenin signaling. Genomic profiling of PEDF knockout livers correlates with gene expression signatures of human HCC associated with aberrant Wnt/β-catenin signaling. PEDF is an endogenous inhibitor of Wnt/β-catenin signaling.

Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide.[@bib1] Genomic profiling has classified HCC based on molecular "signatures" that correlate with biological characteristics and clinical outcomes.[@bib2], [@bib3] One finding from these studies is the role of the extracellular matrix (ECM) in determining tumor behavior.[@bib4], [@bib5], [@bib6] For instance, modulators of the ECM can activate developmental pathways such as Wnt/β-catenin signaling, thereby connecting liver fibrosis to a signaling pathway that drives hepatocarcinogenesis.[@bib3]

Pigment epithelium-derived factor (PEDF) is a circulating 50-kDa protein with ECM binding domains and broad tumor suppressive properties.[@bib7], [@bib8], [@bib9], [@bib10] In PEDF knockout (KO) mice, stromal abnormalities occur in multiple organs including the prostate, pancreas, and liver.[@bib11], [@bib12], [@bib13], [@bib14], [@bib15] Endogenous liver levels of PEDF decline in experimental and human cirrhosis, and PEDF delivery ameliorates experimental liver fibrosis.[@bib14], [@bib16] PEDF null mice crossed with the *Kras*^*G12D*^ mice resulted in marked stromal changes in the pancreas and an invasive malignant phenotype not seen in the *Kras*^*G12D*^ mutant mice alone.[@bib15] These results indicate that PEDF regulates tissue matrix quiescence and its absence is permissive for malignant transformation.

The antitumor properties of PEDF are typically attributed to an antiangiogenic effect.[@bib10], [@bib17] PEDF, however, inhibits tumor cells in culture, indicating other mechanisms.[@bib17], [@bib18] Park et al[@bib19] identified PEDF's ability to inhibit Wnt/β-catenin signaling in the eye with avid binding to the Wnt coreceptor, low-density lipoprotein receptor-related protein 6 (LRP6). Whether PEDF has systemic effects beyond the eye and inhibits tumor development through an inhibitory effect on Wnt/β-catenin signaling is unclear. Because PEDF is most highly expressed by the liver, a finding recently confirmed in the Human Protein Atlas,[@bib20], [@bib21] and modulates Wnt/β-catenin signaling,[@bib19], [@bib22] we asked whether PEDF functions as an LRP6 antagonist in the liver.

We establish that canonical Wnt3a ligand directly regulates PEDF levels. PEDF, in turn, inhibits Wnt/β-catenin signaling. Consistent with this, livers from PEDF KO mice have a transcriptional profile closely aligned with murine models of hepatocarcinogenesis and human HCC characterized by aberrant Wnt/β-catenin signaling. Knockout and knock-in experiments demonstrate that PEDF inhibits Wnt/β-catenin signaling in murine livers and human HCC cells through its ability to inhibit LRP6 and β-catenin activity. Finally, a chronic Western diet elicited sporadic HCC formation in PEDF KO mice, while the human HCC specimens demonstrated diminished PEDF staining.

Materials and Methods {#sec1}
=====================

Human Hepatocellular Carcinoma, Animals, and Liver Tumor Induction {#sec1.1}
------------------------------------------------------------------

Archival human HCC tissues and their corresponding adjacent livers from 14 patients were obtained from the VA Connecticut Healthcare System according to an approved institutional review board protocol. The PEDF KO mice were bred with age-matched wild-type (WT) littermates on the C57BL/6J background to generate heterozygous breeding pairs, and then PEDF KO and WT offspring were backcrossed for more than 10 generations.[@bib11] The mice were genotyped using a commercially available polymerase chain reaction (PCR) kit (Sigma-Aldrich, St. Louis, MO). All procedures were approved by the Institutional Animal Care and Use Committee of VA CT Healthcare System. A commercial Western diet---TestDiet 4342 (TestDiet, St. Louis, MO): energy (% kcal) from fat (40%), carbohydrate (44%), protein (16%)---or standard chow was given for 26 to 32 weeks to PEDF KO and age-matched controls (n = 12/group) starting at 8 to 12 weeks of age.

RNA Extraction and Gene Arrays {#sec1.2}
------------------------------

Frozen whole liver tissue from five PEDF KO animals and WT controls were maintained in liquid nitrogen until total RNA extraction using the TRIzol method (Invitrogen, Carlsbad, CA). TRIzol-extracted RNA was further purified using the Qiagen RNeasy kit (Qiagen, Valencia, CA), yielding high-quality RNA suitable for microarray analyses (RNA integrity number \>9). The RNA quality was verified using Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA), and the RNA was quantified by NanoDrop (NanoDrop Technologies, Wilmington, DE). For gene expression analysis, 500 ng of total RNA was used to generate biotin-labeled cRNA using the Illumina Total RNA amplification and labeling kit (Ambion, Austin, TX) according to the manufacturer's instructions. The biotinylated cRNA was labeled with fluorescent dye at the Yale Keck Genomic Core Facility (West Haven, CT), hybridized onto a MouseRef-8 v2.0 Expression BeadChip expression array bead chip (Illumina, San Diego, CA) and scanned.

Expression data were analyzed by Genespring GX12 software (Agilent Technologies) after normalization by 75th percentile shift. Only genes with a present signal (signal above background noise) in more than 50% of samples were included in the analysis. Group samples with gene expression correlation coefficients ≤0.95 were excluded (one KO sample). For the statistical analysis, replicate samples were averaged. Differences in gene expression were determined using a moderated *t* test, and multiple hypothesis testing adjustment was made using Benjamini--Hochberg method at a false-discovery rate (FDR) ≤ .05 and by adding a fold expression cutoff of 1.3. Genes differentially expressed in KO mice versus WT were subjected to Gene Ontology (GO) (<http://www.geneontology.org>) and WikiPathways (<http://www.wikipathways.org>) enrichment analysis using the hypergeometric test corrected by Benjamini--Yekutieli method at FDR *q* ≤0.05.

To further extend the analysis, gene set enrichment analysis (GSEA) was used (<http://www.broadinstitute.org/gsea>). GSEA is a computational method that determines whether an a priori defined set of genes shows statistically significant differences between two phenotypes.[@bib23] To identify the gene sets that were statistically significantly enriched, we created a rank-order list by gene expression differences between KO and WT sets. Gene Ontology, KEGG pathways (<http://www.genome.jp>), Reactome (<http://www.reactome.org>), Biocarta (<http://www.biocarta.org>), Pathway interaction database (<http://pid.nci.nih.gov>), and curated gene sets reflecting changes induced by various chemical and genetic perturbances were used to interpret results. FDR *q* value was used to rank the results. Gene sets enriched at FDR *q* value ≤ .05 and nominal *P* \< .05 were considered statistically significant. Gene array data were deposited at <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63643>.

PEDF and PEDF Peptide Restoration {#sec1.3}
---------------------------------

Human full-length PEDF was generated in human embryonic kidney cells as described elsewhere, and its purity confirmed using Coomassie and silver staining (Invitrogen).[@bib12] PEDF was administered (25 μg/kg bwt) by intraperitoneal injection on alternate days for a period of 4 weeks.[@bib24] A 34-mer of human PEDF corresponding to amino acids 44--77 has been previously shown to inhibit neovascularization and inhibit tumor growth, but its role in Wnt signaling is unclear.[@bib17], [@bib25] We interrogated Wnt signaling with a 34-mer that was commercially obtained (NeoBiolab, Cambridge, MA) and used at a concentration of 100μM to evaluate Wnt/β-catenin signaling in vitro.

Cell Culture {#sec1.4}
------------

The human HCC cell lines HepG2 and Huh7 were obtained from the American Type Culture Collection (Manassas, VA), propagated, and kept at the Yale Liver Center (P30DK034989). To obtain conditioned medium (CM), the cells were grown to 80% confluence, washed twice with serum-free media, and then incubated with serum-free media overnight. The CM was obtained after 18--20 hours and was concentrated approximately 40-fold using Amicon Ultra centrifugal filters (Millipore, Billerica, MA) with a 10-kDa cutoff. For PEDF peptide experiments, the medium was removed, washed three times with serum medium, and PEDF 34-mer was added for 2 hours before the lysates were obtained. For the lysates, the cells were scraped in radioimmunoprecipitation assay buffer containing protease and phosphatase inhibitors, incubated on ice, and centrifuged at 10,000*g* for 10 minutes.

Silencing of PEDF and LRP6 With RNAi in Hepatocellular Carcinoma Cells {#sec1.5}
----------------------------------------------------------------------

To reduce PEDF levels in human HCC cells, commercial small interfering RNA (siRNA) constructs targeting PEDF (cat. no. 4392420, 4390771) or scrambled (cat. no. 4390843) sequences (Ambion) were transfected according to the manufacturer's instructions. After 6 hours, the transfection medium was replaced with fresh medium lacking siRNA. After an additional 48 hours, the medium was changed to serum-free medium for 24 hours. CM and cell lysates were obtained as described earlier. The HepG2 cells stably transfected with small-hairpin RNA constructs targeting LRP6 were a gift of Dr. Arya Mani (Yale University School of Medicine). The integrity of PEDF and LRP6 KO was assessed in conditioned medium and in lysates. Measurement of PEDF levels in culture was performed with by a commercial enzyme-linked immunosorbent assay kit (BioProducts, Frederick, MD).

RNA Analysis and Quantitative Polymerase Chain Reaction {#sec1.6}
-------------------------------------------------------

The RNA was isolated using the RNAEasy mini kit (Qiagen). The primer probe sets were obtained from a commercial source (Applied Biosystems, Foster City, CA), and quantitative reverse-transcription PCR was performed on a TaqMan ABI 7500 system (Applied Biosystems) as described elsewhere.[@bib13] Target gene expression was normalized against β-actin.

Immunoblotting {#sec1.7}
--------------

Immunoblotting was performed as described elsewhere.[@bib12] Protein content was determined by Bradford assay. Lysates (20--30 μg total protein) were separated under denaturing conditions on a gradient gel (Bio-Rad Laboratories, Hercules, CA), and transferred to polyvinylidene fluoride membranes. After they were blocked in a 5% milk solution, the membranes were incubated overnight with antibodies. Primary antibodies used were PEDF from Chemicon (Temecula, CA); transforming growth factor-β1 (TGF-β1; 3711S), phospho-LRP6 (2568), total LRP6 (2560), nonphosphorylated (active) β-catenin and total β-catenin, phospho-glycogen synthase kinase-3β (p-GSK3β), total GSK3β, phospho-extracellular-signal-regulated kinase (p-ERK), total ERK (4370), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5174S) from Cell Signaling Technology (Beverly, MA); collagen I (ab6308) from Abcam (Cambridge, MA); collagen III (15946) from Novus Biologicals (Oakville, ON, Canada); and β-actin from Sigma-Aldrich.

Collagen I blots were run under reducing and nonreducing conditions. After washing in Tris-buffered saline and 0.05% Tween, the primary antibody was labeled using a peroxidase-conjugated secondary antibody specific for the primary antibody species. Samples were resolved on a gradient gel and transferred to nitrocellulose membranes. Equivalence of loading was confirmed using β-actin or GAPDH for lysates, or Coomassie stains for CM. Densitometry was performed using the National Institutes of Health ImageJ software (<http://imagej.nih.gov/ij/>).

Hydroxyproline Assays {#sec1.8}
---------------------

Hydroxyproline assays were performed using a commercial kit (BioVision Research, Mountain View, CA). Measurements were performed on four separate occasions using three different sets (n = 3--4/group) of age-matched PEDF KO and control livers.

Second Harmonic Generation Imaging {#sec1.9}
----------------------------------

Second harmonic generation (SHG) imaging preferentially detects type I, and to a lesser extent type III, fibrillar collagen.[@bib26] Multiphoton stimulation combined with tissue clearing was used to visualize fibrillar collagen deposition in volume sections of both WT and KO liver specimens measuring approximately 5 × 5 × 1 mm. Tissue clearing was performed on formalin-fixed organs using benzyl alcohol/benzyl benzoate (BABB) in 2:1 ratio as previously described elsewhere.[@bib27] Briefly, tissue specimens were then dehydrated by graded methanol incubations in 30-minute intervals and then incubated overnight with BABB. SHG was measured on a TriM Scope II multiphoton microscope (LaVision BioTec, Bielefeld, Germany) with 780 nm excitation and 390 nm band pass emission filter using a 0.95 NA, 25× objective (Leica Microsystems GmbH, Wetzlar, Germany) designed specifically for BABB immersion. Tissue volume was determined using intrinsic fluorescence with 960 nm excitation and 600--50 nm band pass filter detection. The SHG signal was collected in reflection: the specimen was placed on a deep-well slide, and a mirror was placed underneath to improve collection efficiency. The imaging parameters were kept constant among the specimens, including laser power and scanning speed as well as detector distance from the specimen. Data were collected in 16-bit depth, and contrast was adjusted using identical intensity thresholds for all images, allowing for direct intensity comparison.

Histology {#sec1.10}
---------

Immunohistochemical analysis was performed as described on 14 sequentially obtained human HCC specimens. Sections were deparaffinized, treated to inhibit endogenous peroxidase, and subjected to antigen retrieval. After incubation with primary antibody, sections were washed and then incubated with biotinylated anti-mouse antiserum. Streptavidin complexed with horseradish peroxidase was added, and labeling was detected using diaminobenzidine. Semiquantitative scoring of the immunohistochemical labeling was evaluated by a pathologist (S.E.C.) using a numerical grading score (1, no staining; 2, focal positivity; 3, moderate; 4, diffuse, strong immunostaining) on 10 nonoverlapping fields per case with normal hepatocytes distant to the tumor margin assessed as "Nl liver."

Statistical Analysis {#sec1.11}
--------------------

The *P* values were calculated, assuming equal sample variance, using a two-tailed Student *t* test on Prism software. *P* \< .05 was considered statistically significant. Values were stated as mean ± standard deviation (SD) or standard error of the mean.

Results {#sec2}
=======

PEDF Secretion Is Wnt3a-Responsive and Depends on the Wnt Coreceptor LRP6 {#sec2.1}
-------------------------------------------------------------------------

We evaluated PEDF regulation by Wnt ligands and dependence upon LRP6. The integrity of the LRP6 KO and the stimulatory effects of high (25 mM) versus low (1 mM) glucose on LRP6 and its effector active (nonphosphorylated) β-catenin were shown ([Figure 1](#fig1){ref-type="fig"}*A*). Canonical Wnt3a (50 ng/mL) led to a greater than twofold increase in PEDF levels that was LRP6 dependent ([Figure 1](#fig1){ref-type="fig"}*B*, *P* \< .01). In the absence of the LRP6, Wnt3a had no effect on PEDF levels. Similarly, Wnt3a had no effect on PEDF levels under 1 mM glucose conditions, likely reflecting markedly suppressed LRP6 levels seen in this condition. Thus, Wnt3a-stimulated induction of PEDF levels are LRP6 dependent.

The noncanonical Wnt pathway includes the Wnt5a ligand and its orphan receptor, ROR2 (receptor tyrosine kinase-like orphan receptor 2), and counters the effects of the canonical pathway.[@bib28] To determine whether PEDF could be modulated by the noncanonical pathway, Wnt5a was added to HepG2 cells with and without LRP6. Wnt5a did not alter PEDF levels under high-glucose conditions in the presence of the LRP6 receptor. When the canonical receptor LRP6 was deleted, Wnt5a significantly suppressed PEDF protein levels ([Figure 1](#fig1){ref-type="fig"}*C*, *P* \< .01). Thus, deletion of LRP6 favors the noncanonical pathway and lowers PEDF under high-glucose conditions.

Similarly, the 1 mM glucose condition leads to a functional depletion of the LRP6 receptor ([Figure 1](#fig1){ref-type="fig"}*A*) without genetic manipulation. Here, the Wnt5a ligand significantly decreased PEDF under scrambled and LRP6 KO conditions indicating that the noncanonical Wnt ligands can decrease PEDF in the setting of diminished LRP6 levels ([Figure 1](#fig1){ref-type="fig"}*C*, *P* \< .01 for low glucose with and without LRP6). Thus, canonical Wnt3a and the noncanonical Wnt5a differentially regulate PEDF levels.

PEDF Knockout Livers Resemble Experimental and Human Hepatocellular Carcinoma Marked by Wnt/β-Catenin Signaling {#sec2.2}
---------------------------------------------------------------------------------------------------------------

To explore PEDF's role in the liver, gene expression profiling was done in KO versus WT livers. There were 1113 gene entities differentially expressed between WT and KO animals at FDR ≤ .05 and 1.3-fold expression cutoffs. Out of 1113 genes 344 were up-regulated in KOs, and 769 were down-regulated ([Supplementary Table 1](#tblS1){ref-type="table"}). Grouping these genes by GO categories using hypergeometric model showed that most up-regulated GO categories were related to extracellular matrix function, lipid metabolism, immune response, DNA replication, phase I and II enzymes (FDR ≤ .05). Most down-regulated GO categories were related to ribosomal and mitochondrial function and numerous primary metabolic processes such as nitrogen compound metabolism, glutamine family amino acid metabolic process, urea cycle, and carboxylic acid metabolism, and peptidase inhibitory activity (FDR \< .05).

To further characterize the gene expression changes in KO mice, GSEA using curated pathways as well as GO categories were performed. Consistent with analysis by moderated *t* test, the GSEA showed that most up-regulated pathways were related to cell proliferation, inflammatory responses, collagen expression, extracellular matrix function, and phase I and phase II enzymatic activity ([Supplementary Table 2](#tblS2){ref-type="table"}). Subsequently, another GSEA was performed to test for similarities between gene expression profiles in PEDF KO mouse livers and curated gene sets representing expression signatures of genetic and chemical perturbation. This analysis showed that the most significantly enriched gene sets represented rodent models and human samples of HCC tissues and various inflammatory liver conditions, suggesting that loss of PEDF leads to gene expression changes similar to those found in HCC ([Table 1](#tbl1){ref-type="table"}, [Supplementary Table 3](#tblS3){ref-type="table"}). In fact, eight out of top 10 enriched gene sets represented rodent models of HCC ([Table 1](#tbl1){ref-type="table"}).

PEDF Knockout Livers Display a Genomic Signature Resembling Hepatocellular Carcinoma Categorized by Wnt/β-Catenin Signaling {#sec2.3}
---------------------------------------------------------------------------------------------------------------------------

Comparison of liver-specific gene expression signatures of genetic and chemical perturbation to PEDF KO livers showed a striking resemblance to various human HCC subsets marked by overactive Wnt/β-catenin signaling ([Table 2](#tbl2){ref-type="table"}).[@bib3], [@bib29], [@bib30], [@bib31] Furthermore, PEDF KO liver expression profiles also correlated with the gene expression patterns of nonliver tissue experimental models where constitutively active mutant β-catenin was overexpressed ([Table 2](#tbl2){ref-type="table"}).[@bib32] Additionally, we observed overexpression of both Fzd 1 and 7, Wnt coreceptors that have been reported to be induced in human HCC specimens and cell lines ([Figure 2](#fig2){ref-type="fig"}).[@bib33] Downstream targets of Wnt/β-catenin signaling, such as *Ccnd1*, *Ccnd3*, and *c-Jun*, were also found to be up-regulated in PEDF KO livers.

PEDF Inhibits Activation of the Wnt Coreceptor LRP6 In Vivo {#sec2.4}
-----------------------------------------------------------

To evaluate concordance with the genomic analysis, we interrogated components of the Wnt/β-catenin signaling pathway in PEDF KO livers before and after PEDF reconstitution. PEDF KO livers showed enhanced phospho-LRP6 levels and active β-catenin compared with WT controls in 7-month-old mice ([Figure 3](#fig3){ref-type="fig"}*A*, *P* \< .02). A similar activation of LRP6 was seen in 2-month-old mice ([Figure 3](#fig3){ref-type="fig"}*B*, *P* \< .05). Restoration of PEDF in KO mice resulted in decreased LRP6 phosphorylation without affecting total LRP6 levels ([Figure 3](#fig3){ref-type="fig"}*C*, *P* = .05). Moreover, gene expression of downstream canonical Wnt signaling pathway targets *Ccnd1* and *c-Jun* was increased in PEDF KO livers versus controls ([Figure 3](#fig3){ref-type="fig"}*D*, *P* \< .05). These results indicate that PEDF functions as an antagonist of hepatic LRP6 activation in vivo and that exogenous PEDF can inhibit LRP6 activation in vivo.

PEDF Loss Is Associated With Increased Fibrogenic Markers and Enhanced Cellular Proliferation {#sec2.5}
---------------------------------------------------------------------------------------------

PEDF expression is reduced in human cirrhosis, and its restoration in two different models of experimental liver cirrhosis mitigates fibrotic changes.[@bib14], [@bib16] Consistent with this finding, the GSEA revealed an induction of pathways related to extracellular matrix deposition in PEDF KO liver tissue ([Figure 4](#fig4){ref-type="fig"}*A*, [Supplementary Table 1](#tblS1){ref-type="table"}). Biochemical assessment of collagen content and specific collagen subtypes, however, revealed a more complex picture of the matricellular changes in the absence of PEDF.

Confirmation of fibrogenic cytokines with quantitative PCR showed that *tgfb1* and *pdgfa* were significantly increased, and *thbs1*, an activator of transforming growth factor-β, showed a trend toward increased expression ([Figure 4](#fig4){ref-type="fig"}*B*). Angiogenic factors play a role in promoting fibrogenesis and can be regulated by Wnt pathway activation.[@bib34] Enhanced expression of *vegfa* was present in PEDF KO livers ([Figure 4](#fig4){ref-type="fig"}*B*). Similarly, expression of *col1a* was increased but not that of other fibrillar collagen types such as *col5a*1. Surprisingly, the total hydroxyproline content of PEDF KO livers was 75% of the control livers ([Figure 4](#fig4){ref-type="fig"}*C*), indicating that overall the collagen content was decreased. However, SHG imaging revealed visual evidence of increased fibrillar collagen in PEDF KO livers ([Figure 4](#fig4){ref-type="fig"}*D*). Consistent with the SHG imaging, the fibrillar collagen types I and III levels in PEDF KO livers were higher than in the controls ([Figure 4](#fig4){ref-type="fig"}*E*). Thus, a preferential induction of fibrillar collagen occurs in PEDF KO livers, but it is accompanied by an overall decrease in other collagen or structural proteins that contain hydroxyproline residues.

PEDF Is a Secreted Antagonist of Wnt/β-Catenin Signaling in Hepatocellular Carcinoma Cells {#sec2.6}
------------------------------------------------------------------------------------------

Findings in murine livers were extended to human HCC cells to determine whether PEDF functions as a Wnt antagonist. Both HepG2 and Huh7 cells secreted PEDF into the CM ([Figure 5](#fig5){ref-type="fig"}*A* and *C*). In HepG2 cells, siRNA-mediated PEDF knockdown led to increased phospho-LRP6 and active β-catenin levels ([Figure 5](#fig5){ref-type="fig"}*A* and *B*, *P* \< .01). Similar results were observed in Huh-7 cells after PEDF knockdown ([Figure 5](#fig5){ref-type="fig"}*C* and *D*, *P* \< .01).

A 34-mer sequence within PEDF mediates its well-documented antiangiogenic effects.[@bib25] Because angiogenesis requires Wnt signaling, we surmised that the PEDF 34-mer is responsible for its effects on Wnt/β-catenin signaling. Adding the PEDF 34-mer decreased the levels of active phospho-LRP6 and active β-catenin ([Figure 5](#fig5){ref-type="fig"}*E*, *P* \< .01). Downstream regulators and targets of Wnt signaling such as GSK3β and phospho-ERK levels corresponded to the effects of Wnt blockade with PEDF 34-mer ([Figure 5](#fig5){ref-type="fig"}*F*). Levels of phospho-GSK3β (inactive form) were diminished consistent with increased intracellular active GSK3β and enhanced degradation of β-catenin seen with Wnt blockade. The downstream targets of β-catenin such as phospho-ERK were decreased. Moreover, transcriptional targets of canonical Wnt signaling such as *ccnd1* and *c-Jun* were suppressed with the 34-mer ([Figure 5](#fig5){ref-type="fig"}*G*). These results demonstrate that PEDF antagonizes Wnt/β-catenin signaling in human HCC cells and point to a 34-amino-acid peptide fragment derived from PEDF that mediates LRP6 blockade.

Induction of Liver Fibrosis and Sporadic Hepatocellular Carcinoma in PEDF Knockout Mice After Western Diet Feeding {#sec2.7}
------------------------------------------------------------------------------------------------------------------

Genomic profiling of PEDF KO livers corresponded to various human HCC subsets marked by overactive Wnt/β-catenin, but spontaneous HCC did not develop in PEDF KO mice up to 1 year of age (data not shown). To test whether diet-induced obesity could induce HCC formation in the absence of PEDF, a Western diet (40% fat, 44% carbohydrate, 16% protein) was given to PEDF KO and WT mice for 6 to 8 months. A Western diet increased fibrosis in WT and PEDF KO mice as shown by trichrome staining and hydroxyproline measurements ([Figure 6](#fig6){ref-type="fig"}*A*).

Increased fibrillar collagen deposition as seen with SHG imaging was more apparent in PEDF KO than WT livers ([Figure 6](#fig6){ref-type="fig"}*B*). Three-dimensional reconstructed images from SHG imaging revealed an increase in fibrillar collagen adjacent to vessels, outlining their structures ([Figure 6](#fig6){ref-type="fig"}*B*). A subset of PEDF KO mice (3 of 12) developed macroscopic tumor formation compared with none (0 of 12) in the control mice ([Figure 6](#fig6){ref-type="fig"}*C*) after chronic Western diet feeding. Histologic examination showed features consistent with a well-differentiated HCC with the increased presence of unpaired blood vessels ([Figure 6](#fig6){ref-type="fig"}*C*, *arrows*). In contrast to the diet-induced HCC, a one-time diethylnitrosamine injection did not result in HCC formation in either the WT or KO mice at 6 months (data not shown). Thus, PEDF deficiency combined with a chronic Western diet led to sporadic HCC formation.

PEDF Expression Is Reduced in Human Hepatocellular Carcinoma Specimens {#sec2.8}
----------------------------------------------------------------------

A previous study of embryonic and adult human tissue sites demonstrated that the liver has the highest expression levels of the PEDF gene, and the recent tissue-based map of the human proteome confirmed this finding.[@bib20], [@bib21] Relative to the high endogenous levels in the normal liver, we asked whether PEDF levels in HCC specimens were diminished. Staining of PEDF showed diffuse and strong immunoreactivity for PEDF in normal liver tissue ([Figure 7](#fig7){ref-type="fig"}*A*, *left).* In contrast, PEDF immunolabeling was statistically significantly reduced in HCC compared with the adjacent liver ([Figure 7](#fig7){ref-type="fig"}*A*, *middle* and *right,* and *B*; *P* \< .01). Thus, human HCC specimens demonstrated decreased PEDF expression compared with the adjacent nontransformed hepatocytes.

Discussion {#sec3}
==========

Aberrant Wnt/β-catenin signaling underlies a number of malignancies, including HCC.[@bib3], [@bib35] Our study has identified PEDF as an endogenous inhibitor of LRP6 activation that is secreted in response to canonical Wnt ligands. Enhanced LRP6 and β-catenin activation was seen in the livers of PEDF KO mice and in two human HCC cell lines where PEDF was depleted. Further, adding a PEDF 34-mer inhibited LRP6, active β-catenin, and downstream targets of Wnt signaling, thereby identifying the region on PEDF that mediates Wnt inhibitory effects. These data support the idea that PEDF functions as a part of a negative feedback loop to modulate Wnt signaling. Gene enrichment data supported this interaction. Further, biochemical analyses of PEDF KO murine livers before and after PEDF reconstitution in vivo confirmed that PEDF can block Wnt signaling in the liver. PEDF knockdown in two human HCC cell lines led to increased Wnt/β-catenin signal transduction with a specific 34-amino-acid region mediating these effects. Thus, PEDF is regulated by and inhibits the canonical Wnt/β-catenin pathway in the murine liver and in two human HCC cell lines.

The genomic analysis in this study correlated with genetic profiles of murine hepatocarcinogenesis and human HCC subsets marked by overactive Wnt/β-catenin signaling, but PEDF deficiency alone did not result in HCC formation. A prolonged nutritional challenge induced only a fraction of animals to develop a well-differentiated HCC. These results are consistent with models of hepatic overexpression of normal and mutant β-catenin that do not result in spontaneous HCC.[@bib35] Paradoxically, deletion of β-catenin from the liver is permissive for HCC formation after injection with diethylnitrosamine.[@bib36] This surprising effect of β-catenin deletion conferring an increased rate of HCC development in murine models, rather than its overexpression, reflects the importance of this pathway for liver tissue homeostasis. In its absence, the liver is prone to injury from oxidative stress and enhanced fibrosis.[@bib36] Thus, findings from β-catenin transgenic mice are at odds with those from genomic and immunohistochemical studies in human HCC, which point to Wnt/β-catenin signaling as a significant driver in a subset of HCC.[@bib3] The absence of HCC found in transgenic models of β-catenin overexpression and the occurrence of HCC with β-catenin deletion highlights the limitations of constitutively active or deletion of β-catenin, where temporal and context-specific activity of β-catenin may more accurately capture its role in human disease.

Absence of PEDF led to complex changes to the ECM of the liver. Despite lower total hydroxyproline levels, type I/III collagen content and SHG imaging demonstrated increased deposition of fibrillar collagen in PEDF KO livers. In experimental and human cirrhosis specimens, PEDF levels are also depleted.[@bib14] Restoration of PEDF in experimental models of CCl~4~ \[chemokine (C-C motif) ligand 4\] and bile-duct ligated cirrhosis ameliorates tissue fibrosis, suggesting an important role for endogenous PEDF in maintaining quiescence of the liver ECM.[@bib14], [@bib16] These findings are consistent with studies that demonstrate Wnt/β-catenin signaling as a regulator of the fibrotic response in diverse organs.[@bib37], [@bib38], [@bib39] Further, examination of the PEDF null state in humans, osteogenesis imperfecta type VI, points to abnormalities in the extracellular matrix.[@bib24], [@bib40] These findings suggest that PEDF may regulate matricellular content in multiple organ sites.

This study provides further evidence to support the role of PEDF in Wnt/β-catenin signaling. The discovery through exome sequencing that null mutations in PEDF cause osteogenesis imperfecta type VI implicated PEDF's role in modulating Wnt/β-catenin signaling in human disease.[@bib22], [@bib40], [@bib41] We and others have shown that PEDF could induce differentiation of progenitor cells and that these effects were LRP6 dependent.[@bib22], [@bib42] In the eye, PEDF inhibited Wnt3a-mediated β-catenin nuclear translocation, and recent studies showed that PEDF directly suppressed other Wnt modulators such as sclerostin.[@bib19], [@bib41] Exogenous PEDF protein and a peptide derived from PEDF demonstrate inhibitory effects on Wnt signaling in the liver and in two HCC cell lines, thereby pointing to its role in attenuating Wnt signaling in a negative feedback loop.

Interestingly, PEDF appears to promote Wnt/β-catenin signaling in stem cell populations but inhibits Wnt signaling in differentiated cells.[@bib22], [@bib41] Differential effects are also seen in Wnt ligands and Wnt-related proteins such as Wnt5a and Dickkopf2, and stem from selective expression patterns of Wnt coreceptors.[@bib28], [@bib43], [@bib44] Future studies detailing the expression patterns of different Fzd species should allow identification of the receptor combination that directs PEDF's different functional outcomes as they pertain to Wnt signaling.

In summary, PEDF functions as an endogenous inhibitor of Wnt/β-catenin signaling in the liver and in human HCC cells. These findings provide a framework for understanding the antitumor properties of PEDF in other cancer types.

Appendix {#appsec1}
========
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Up-Regulated List Truncated at FDR \< .005Database Web Link: (<http://www.broadinstitute.org/gsea/msigdb/genesets.jsp?collection=CGP>)NameNESFDR *q* ValueLEE_LIVER_CANCER_ACOX1_UP3.117.000LEE_LIVER_CANCER_E2F1_UP3.017.000LEE_LIVER_CANCER_MYC_E2F1_UP2.984.000LEE_LIVER_CANCER_MYC_TGFA_UP2.911.000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP2.892.000KHETCHOUMIAN_TRIM24_TARGETS_UP2.891.000LEE_LIVER_CANCER_CIPROFIBRATE_UP2.858.000LEE_LIVER_CANCER_DENA_UP2.780.000WIELAND_UP_BY_HBV_INFECTION2.772.000BORLAK_LIVER_CANCER_EGF_UP2.742.000SERVITJA_LIVER_HNF1A_TARGETS_UP2.742.000SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM32.697.000SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM22.635.000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN2.622.000DEMAGALHAES_AGING_UP2.605.000POOLA_INVASIVE_BREAST_CANCER_UP2.580.000HECKER_IFNB1_TARGETS2.516.000BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN2.507.000MCLACHLAN_DENTAL_CARIES_DN2.476.000LE_EGR2_TARGETS_UP2.445.000HOSHIDA_LIVER_CANCER_SUBCLASS_S12.403.000KIM_GLIS2_TARGETS_UP2.390.000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP2.385.000ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION2.374.000JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP2.373.000MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN2.366.000STEARMAN_TUMOR_FIELD_EFFECT_UP2.361.000BURTON_ADIPOGENESIS_32.357.000FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP2.355.000MCBRYAN_PUBERTAL_BREAST_4\_5WK_UP2.340.000ONDER_CDH1_TARGETS_2\_DN2.328.000MCBRYAN_PUBERTAL_BREAST_6\_7WK_DN2.322.000ISHIDA_E2F_TARGETS2.297.000KORKOLA_TERATOMA2.292.000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP2.290.000PASINI_SUZ12_TARGETS_DN2.262.001MIKKELSEN_NPC_HCP_WITH_H3K27ME32.253.001CHANG_CYCLING_GENES2.253.001MOSERLE_IFNA_RESPONSE2.252.001ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR2.250.001BOYLAN_MULTIPLE_MYELOMA_C\_D_DN2.244.001PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP2.233.001WENG_POR_TARGETS_LIVER_UP2.233.001KANG_DOXORUBICIN_RESISTANCE_UP2.232.001ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP2.231.001MCLACHLAN_DENTAL_CARIES_UP2.229.001LENAOUR_DENDRITIC_CELL_MATURATION_UP2.226.001BROWN_MYELOID_CELL_DEVELOPMENT_UP2.222.001YAGI_AML_FAB_MARKERS2.216.001NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP2.214.001JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP2.212.001TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP2.209.001YAMASHITA_METHYLATED_IN_PROSTATE_CANCER2.195.001STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN2.193.001GAL_LEUKEMIC_STEM_CELL_DN2.193.001ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN2.188.001TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP2.186.001CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP2.163.001WALLACE_PROSTATE_CANCER_RACE_UP2.163.001WHITFIELD_CELL_CYCLE_LITERATURE2.162.001MORI_IMMATURE_B\_LYMPHOCYTE_UP2.159.001SMID_BREAST_CANCER_LUMINAL_B\_DN2.159.001CROONQUIST_NRAS_SIGNALING_DN2.155.001TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN2.154.001CROONQUIST_IL6_DEPRIVATION_DN2.151.001DELYS_THYROID_CANCER_UP2.149.001MURATA_VIRULENCE_OF_H\_PILORI2.148.001LI_INDUCED_T\_TO_NATURAL_KILLER_UP2.144.001SERVITJA_ISLET_HNF1A_TARGETS_UP2.131.001HAN_JNK_SINGALING_DN2.129.001WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF22.122.001BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN2.119.001GOLDRATH_ANTIGEN_RESPONSE2.119.001ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR2.115.001YU_MYC_TARGETS_UP2.114.001SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP2.113.001RODWELL_AGING_KIDNEY_NO_BLOOD_UP2.107.001LIAN_LIPA_TARGETS_3M2.097.002TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP2.097.002SWEET_KRAS_TARGETS_UP2.096.002TSAI_RESPONSE_TO_RADIATION_THERAPY2.094.002MIKKELSEN_MCV6_HCP_WITH_H3K27ME32.094.002MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN2.093.002RHODES_UNDIFFERENTIATED_CANCER2.092.002CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN2.090.002HAN_JNK_SINGALING_UP2.089.002AMIT_SERUM_RESPONSE_40_MCF10A2.088.002WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP2.087.002LIAN_LIPA_TARGETS_6M2.086.002AKL_HTLV1_INFECTION_UP2.081.002OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP2.081.002LEE_EARLY_T\_LYMPHOCYTE_UP2.080.002LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN2.080.002KATSANOU_ELAVL1_TARGETS_UP2.079.002VANHARANTA_UTERINE_FIBROID_UP2.074.002CHICAS_RB1_TARGETS_GROWING2.073.002RODWELL_AGING_KIDNEY_UP2.072.002VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP2.067.002ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP2.067.002LIM_MAMMARY_LUMINAL_MATURE_DN2.066.002KENNY_CTNNB1_ßTARGETS_UP2.050.002BASAKI_YBX1_TARGETS_UP2.046.002LIANG_SILENCED_BY_METHYLATION_UP2.045.002CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN2.038.003KEEN_RESPONSE_TO_ROSIGLITAZONE_DN2.036.003DAUER_STAT3_TARGETS_DN2.035.003KAMMINGA_EZH2_TARGETS2.032.003CHANG_IMMORTALIZED_BY_HPV31_DN2.031.003KOBAYASHI_EGFR_SIGNALING_24HR_DN2.027.003JEON_SMAD6_TARGETS_UP2.022.003IGLESIAS_E2F_TARGETS_UP2.017.004DAZARD_UV_RESPONSE_CLUSTER_G242.016.004SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP2.008.004ROSS_AML_WITH_CBFB_MYH11_FUSION2.007.004URS_ADIPOCYTE_DIFFERENTIATION_DN2.006.004DAZARD_RESPONSE_TO_UV_SCC_UP2.006.004VERHAAK_AML_WITH_NPM1_MUTATED_UP2.006.004GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP2.004.004MEISSNER_BRAIN_HCP_WITH_H3K27ME32.001.004KAMIKUBO_MYELOID_CEBPA_NETWORK1.998.004VERHAAK_GLIOBLASTOMA_NEURAL1.997.004LIANG_SILENCED_BY_METHYLATION_21.992.004TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN1.989.005TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP1.980.005MCDOWELL_ACUTE_LUNG_INJURY_UP1.974.005Down-Regulated Chemical and Genetic Perturbation Data SetsDatabase Web Link: (<http://www.broadinstitute.org/gsea/msigdb/genesets.jsp?collection=CGP>)NameNESFDR *q* ValueHSIAO_LIVER_SPECIFIC_GENES−2.829.000LEE_LIVER_CANCER_SURVIVAL_UP−2.743.000OHGUCHI_LIVER_HNF4A_TARGETS_DN−2.645.000BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES−2.596.000CAIRO_HEPATOBLASTOMA_DN−2.601.000CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN−2.526.001BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN−2.529.001CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP−2.483.003SU_LIVER−2.408.011SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4−2.351.025BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN−2.327.028HOSHIDA_LIVER_CANCER_SUBCLASS_S3−2.331.030SERVITJA_LIVER_HNF1A_TARGETS_DN−2.310.030WOO_LIVER_CANCER_RECURRENCE_DN−2.314.030CAIRO_LIVER_DEVELOPMENT_DN−2.279.039LEE_LIVER_CANCER_ACOX1_DN−2.241.051[^3]
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![**PEDF secretion is regulated by Wnt ligands in an LRP6-dependent manner.** (*A*) Integrity of the LRP6 small-hairpin RNA-mediated knockdown in HepG2 cells was demonstrated under high (25 mM) and low (1 mM) glucose conditions. (*B*) Canonical Wnt3a ligand significantly induces PEDF levels in the presence of the Wnt coreceptor LRP6 (*P* \< .01). Genetic knockdown of LRP6 or its functional depletion with 1 mM glucose abrogates this effect (not statistically significant). (*C*) The noncanonical Wnt5a suppresses PEDF levels when LRP6 is genetically deleted under 25 mM glucose or reduced by low glucose (*P* \< .01). Experiments were conducted in duplicate with n = 3--4/group. Data are presented as mean ± SD.](gr1){#fig1}

![**Expression profiling of PEDF knockout (KO) livers demonstrates up-regulation of genes involved in Wnt/β-catenin signaling.** Items in red represent genes that were up-regulated \<1.1-fold in PEDF KO compared with wild-type (WT) livers. In particular, Frizzled ligands known to play a role in hepatocarcinogenesis were up-regulated. Induction of multiple downstream targets of Wnt/β-catenin (*Ccnd1*, *Ccnd3*, *Jun*, and *Plau*) suggests transcriptional activation of Wnt/β-catenin signaling.](gr2){#fig2}

![**PEDF inhibits LRP6 phosphorylation in murine livers.** (*A*) Increased phospho-LRP6 and nonphosphorylated (active) β-catenin in 7-month-old PEDF knockout (KO) mice and corresponding quantification of immunoblots (*P* \< .02). (*B*) Younger 2 month-old) PEDF KO mice also show increased phosphorylation of LRP6 (*P* \< .05). (*C*) PEDF restoration in vivo reduces LRP6 activation (*P* = .05). (*D*) Gene expression of *Ccnd1* and *c-Jun* in murine control and PEDF KO livers. Representative data from duplicate experiments conducted with n = 3--4/group for immunoblots. Quantitative reverse-transcription polymerase chain reaction data, n = 6/group. Data are presented as mean ± SD.](gr3){#fig3}

![**Absence of PEDF is permissive for induction of fibrogenic markers.** (*A*) Gene expression heat maps show up-regulation of DNA replication, collagen, and extracellular matrix organization pathways. Heat maps represent graphic gene expressions of the genes contributing most to statistically significant enrichment score in gene set enrichment analysis (core enriched genes). The log transformed color expression scale is shown at the bottom of the figure. (*B*) PEDF KO livers demonstrate enhanced expression of profibrotic cytokines (*tgfb1*, *P* \< .05; *pdgfa*, *P* \< .01, *vegfa*, *P* \< .01) and fibrillar collagen. (*C*) Decreased hydroxyproline in PEDF KO livers. (*D*) Second harmonic generation (SHG) imaging demonstrates enhanced fibrillar collagen deposition adjacent to vessels in PEDF KO livers. (*E*) Transforming growth factor-β (TGF-β) and fibrillar type I and III collagens were increased in PEDF KO livers under reducing and nonreducing conditions. Quantitative reverse-transcription polymerase chain reaction data, n = 5--6/group; data are presented as mean ± S.E.M. Representative SHG images taken from n = 3/group. Representative hydroxyproline data from n = 4 separate experiments from three different sets of age-matched livers; data are presented as mean ± SD. Immunoblots are from n = 3 livers/group from three separate experiments; data are presented as mean ± SD.](gr4){#fig4}

###### 

**PEDF inhibits canonical Wnt/β-catenin signaling in human hepatocellular carcinoma (HCC) cells.** (*A*) PEDF knockdown in HepG2 cells results in increased LRP6 phosphorylation and increased active β-catenin. (*B*) Corresponding quantification of phospho-LRP6 and active β-catenin after RNA interference of PEDF in HepG2 cells (*P* \< .01). (*C*) Huh-7 cells display increased LRP6 phosphorylation and active β-catenin after depletion of endogenous PEDF. (*D*) Quantification of phospho-LRP6 and active β-catenin after RNA interference of PEDF in Huh-7 cells (*P* \< .01). (*E*) A PEDF 34-mer peptide decreased LRP6 phosphorylation and active β-catenin levels in Huh-7 cells (*P* \< .01). (*F*) Changes in the levels of downstream targets of canonical Wnt signaling such as phospho-GSK3β/total GSK3β and phospho-ERK/total ERK reflect inhibition of Wnt signaling with the PEDF 34-mer. (*G*) Gene targets of the Wnt pathway, *ccnd1* and *c-Jun,* were significantly suppressed with PEDF 34-mer (*P* \< .05 and *P* \< .01, respectively). Representative data are shown from three separate experiments conducted with n = 3/group for siRNA experiments. Data from 34-mer peptide experiments were performed in duplicate and n = 3/group. Data are presented as mean ± SD.

![](gr5ad)

![](gr5eg)

![**A Western diet induces liver fibrosis and sporadic hepatocellular carcinoma (HCC) in PEDF knockout (KO) mice.** (*A*) Six months of Western diet feeding induced liver fibrosis in wild-type (WT) and PEDF KO mice as demonstrated by trichrome staining (magnification 20×; size bars: 100 μM) and measured by hydroxyproline content. (*B*) Second harmonic generation (SHG) imaging shows increased fibrillar type I/III collagen deposition in PEDF KO mice livers (*bottom panels*) compared with WT (*top panels*) mice fed a Western diet. Magnification: *left* 4×; *right* 20×. Three-dimensional reconstruction of serial SHG images reveals prominence of fibrillar collagen around blood vessels in PEDF KO livers. (*C*) PEDF KO mice showing macroscopic tumor in mice fed the Western diet versus control diet. Bottom panel shows histology of a well-differentiated HCC arising in KO mouse fed a Western diet. L, liver; T, tumor; magnification 10×, arrow at demarcation between liver and HCC; 20×, arrows highlighting unpaired blood vessels in HCC.](gr6){#fig6}

![**PEDF expression is reduced in human hepatocellular carcinoma (HCC).** (*A*) Immunostaining for PEDF in human livers (*top*) and human HCC specimens (*bottom*). (*B*) Semiquantitative scoring of PEDF staining demonstrates increased labeling in normal liver compared with HCC specimens (*P* \< .01; n = 14). NL, normal.](gr7){#fig7}

###### 

Top 10 Enriched Chemical and Genetic Perturbation Gene Sets Corresponding to PEDF Null Livers

  Gene Set Name                             FDR *q* Value[a](#tbl1fna){ref-type="table-fn"}   Gene Set Description
  ----------------------------------------- ------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------
  LEE_LIVER_CANCER_ACOX1_UP                 \<.001                                            Genes up-regulated in HCC of ACOX1 knockout mice
  LEE_LIVER_CANCER_E2F1_UP                  \<.001                                            Genes up-regulated in HCC induced by overexpression of E2F1
  LEE_LIVER_CANCER_MYC_E2F1_UP              \<.001                                            Genes up-regulated in HCC from MYC and E2F1 double transgenic mice
  LEE_LIVER_CANCER_MYC_TGFA_UP              \<.001                                            Genes up-regulated in HCC tissue of MYC and TGFA double transgenic mice
  ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP   \<.001                                            Hepatic graft versus host disease day 35: genes up-regulated in allogeneic vs syngeneic bone marrow transplant
  KHETCHOUMIAN_TRIM24_TARGETS_UP            \<.001                                            Retinoic acid-responsive genes up-regulated in HCC samples of TRIM24 knockout mice
  LEE_LIVER_CANCER_CIPROFIBRATE_UP          \<.001                                            Genes up-regulated in HCC induced by ciprofibrate
  LEE_LIVER_CANCER_DENA_UP                  \<.001                                            Genes up-regulated in HCC induced by diethylnitrosamine
  WIELAND_UP_BY_HBV_INFECTION               \<.001                                            Genes induced in the liver during hepatitis B viral clearance in chimpanzees
  BORLAK_LIVER_CANCER_EGF_UP                \<.001                                            Genes up-regulated in HCC developed by transgenic mice overexpressing a secreted form of epidermal growth factor in liver

Note: Gene set enrichment analysis showed that expression signatures in PEDF knockout mouse livers resembled those found in genetic and chemical models of HCC. Of the top 10 enriched chemical and genetic perturbation gene sets, eight represented rodent models of HCC, and two (Ichiba and Wieland) sets are related to inflammatory liver conditions. HCC, hepatocellular carcinoma.

FDR (false-discovery rate): adjusted *P* value (FDR *q* value).

###### 

Up-Regulated Gene Sets From PEDF KO Livers Matching Gene Expression Signatures Associated With Aberrant Wnt/β-Catenin Signaling

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Name                                      FDR[a](#tbl2fna){ref-type="table-fn"}   Description, Web Link, and PubMed ID
  ----------------------------------------- --------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HOSHIDA LIVER CANCER SUBCLASS S1          \<.001                                  Gene signature from HCC subset with aberrant Wnt activation\
                                                                                    <http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S1>\
                                                                                    PUBMED ID: [19723656](pmid:19723656){#intref0090}

  KENNY CTNNB1 TARGETS UP                   .002                                    Genes up-regulated in mammary epithelial cells with constitutively active mutant β-catenin gene\
                                                                                    <http://www.broadinstitute.org/gsea/msigdb/cards/KENNY_CTNNB1_TARGETS_UP.html>\
                                                                                    PUBMED ID: [15642117](pmid:15642117){#intref0100}

  CAVARD LIVER CANCER MALIGNANT VS BENIGN   .003                                    Genes identified by subtractive hybridization to compare gene expression between malignant and benign components of a human HCC occurring from pre-existing adenoma with activated β-catenin\
                                                                                    <http://www.broadinstitute.org/gsea/msigdb/cards/CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN.html>\
                                                                                    PUBMED ID: [16314847](pmid:16314847){#intref0110}

  CHIANG LIVER CANCER SUBCLASS CTNNB1 UP    .031                                    Genes up-regulated in the subclass of HCC characterized by activated β-catenin (*CTNNB1*) gene\
                                                                                    <http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP.html>\
                                                                                    PUBMED ID: [18701503](pmid:18701503){#intref0120}

  CAIRO HEPATOBLASTOMA UP                   .050                                    Gene signature from human hepatoblastoma characterized by Wnt/β-catenin activation\
                                                                                    <http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_UP.html>\
                                                                                    PUBMED ID: [19061838](pmid:19061838){#intref0130}
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FDR (false-discovery rate): adjusted *P* value (FDR *q* value).

[^1]: P.P. and J.G. contributed equally to this work.

[^2]: Note: FDR (false-discovery rate), FDR *q* value; NES, normalized enrichment score.

[^3]: Note: FDR (false-discovery rate) *q* value: adjusted *P* value; NES, normalized enrichment score.
